Role of cytomegalovirus (CMV) IgG avidity testing in diagnosing primary CMV infection during pregnancy

Clinical and Vaccine Immunology

Volumn 21, Issue 10, 2014, Pages 1377-1384

  Prince, Harry E ^a   Lapé Nixon, Mary ^a  

^a Focus Diagnostics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ANTIGEN EXPRESSION; BINDING AFFINITY; CONCEPTION; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IGG AVIDITY TESTING; IMMUNOASSAY; IMMUNOBLOTTING; IMMUNOLOGY TEST KIT; INFECTION RISK; NONHUMAN; PREGNANCY; PREGNANT WOMAN; PRIMARY INFECTION; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS TRANSMISSION; ANTIBODY AFFINITY; BLOOD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; IMMUNOLOGY; PREGNANCY COMPLICATIONS, INFECTIOUS; TIME;

ANTIBODIES, VIRAL; ANTIBODY AFFINITY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOGLOBULIN G; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TIME FACTORS;

EID: 84907567648     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00487-14     Document Type: Review

References (68)

1. Coll O, Benoist G, Ville Y, Weisman LE, Botet F, the WAMP Infections Working Group, Anceschi MM, Greenough A, Gibbs RS, Carbonell-Estrany X. 2009. Guidelines on CMV congenital infection. J. Perinat. Med. 37:433-445. http://dx.doi.org/10.1515/JPM.2009.127.
2. Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. 2013. The "silent" global burden of congenital cytomegalovirus. Clin. Microbiol. Rev. 26:86-102. http://dx.doi.org/10.1128/CMR.00062-12.
3. Revello MG, Gerna G. 2002. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin. Microbiol. Rev. 15:680-715. http://dx.doi.org/10.1128/CMR.15.4.680 -715.2002.
4. Baer HR, McBride HE, Caviness AC, Demmler-Harrison GJ. 2014. Survey of congenital cytomegalovirus (cCMV) knowledge among medical students. J. Clin. Virol. 60:222-242. http://dx.doi.org/10.1016/j.jcv.2014.03.023.
5. Revello MG, Fabbri E, Furione M, Zavattoni M, Lilleri D, Tassis B, Quarenghi A, Cena C, Arossa A, Montanari L, Rognoni V, Spinillo A, Gerna G. 2011. Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: a 20-year experience. J. Clin. Virol. 50:303-307. http://dx.doi.org/10.1016/j.jcv.2010.12.012.
6. Guerra B, Simonazzi G, Banfi A, Lazzarotto T, Farina A, Lanari M, Rizzo N. 2007. Impact of diagnostic and confirmatory tests and prenatal counseling on the rate of pregnancy termination among women with seropositive cytomegalovirus immunoglobulinMantibody titers. Am. J. Obstet. Gynecol. 221:e1-e6. http://dx.doi.org/10.1016/j.ajog.2006.08.039.
7. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll Alford TJCA. 1992. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N. Engl. J. Med. 326:663-667. http://dx.doi.org/10.1056/NEJM199203053261003.
8. Stagno S, Pass RF, Cloud G, Britt WJ, Henderson RE, Walton PD, Veren DA, Page F, Alford CA. 1986. Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA 256:1904-1908.
9. Revello MG, Gerna G. 1999. Diagnosis and implications of human cytomegalovirus infection in pregnancy. Fetal Matern. Med. Rev. 11:117-134. http://dx.doi.org/10.1017/S0965539599000327.
10. Revello MG, Gerna G. 2004. Pathogenesis and prenatal diagnosis of human cytomegalovirus infection. J. Clin. Virol. 29:71-83. http://dx.doi.org/10.1016/j.jcv.2003.09.012.
11. Lazzarotto T, Guerra B, Lanari M, Gabrielli L, Landini MP. 2008. New advances in the diagnosis of congenital cytomegalovirus infection. J. Clin. Virol. 41:192-197. http://dx.doi.org/10.1016/j.jcv.2007.10.015.
12. Hazell SL. 2007. Clinical utility of avidity assays. Expert Opin. Med. Diagn. 1:511-519. http://dx.doi.org/10.1517/17530059.1.4.511.
13. De Paschale M, Agrappi C, Manco MT, Clerici P. 2010. Positive predictive value of anti-HCMV IgM as an index of primary infection. J. Virol. Methods 168:121-125. http://dx.doi.org/10.1016/j.jviromet.2010.05.001.
14. Chakravarti A, Kashyap B, Wadhwa A. 2007. Relationship of IgG avidity index and IgM levels for the differential diagnosis of primary from recurrent cytomegalovirus infections. Iran. J. Allergy Asthma Immunol. 6:197-201.
15. Leruez-Ville M, Sellier Y, Salomon LJ, Stirnemann JJ, Jacquemard F, Ville Y. 2013. Prediction of fetal infection in cases with cytomegalovirus immunoglobulin M in the first trimester of pregnancy: a retrospective cohort. Clin. Infect. Dis. 56:1428-1435. http://dx.doi.org/10.1093/cid/cit059.
16. BaAlawi F, Robertson PW, Lahra M, Rawlinson WD. 2012. Comparison of five CMV IgM immunoassays with CMV IgG avidity for diagnosis of primaryCMVinfection. Pathology 44:381-383. http://dx.doi.org/10.1097/PAT.0b013e328353bec0.
17. Kouri V, Correa CB, Verdasquera D, Martinez PA, Alvarez A, Aleman Y, Perez L, Golpe MA, Someilan T, Chong Y, Fresno C, Navarro MA, Perez E, Moro I, Sanchez R, Llanusa C, Melin P. 2010. Diagnosis and screening for cytomegalovirus infection in pregnant women in Cuba as prognostic markers of congenital infection in newborns 2007-2008. Pediatr. Infect. Dis. J. 29:1105-1110. http://dx.doi.org/10.1097/INF.0b013e3181eb7388.
18. Kamel N, Metwally L, Sayed Ahmed WA, Lotfi M, Younis S. 2014. Primary cytomegalovirus infection in pregnant Egyptian women confirmed by cytomegalovirus IgG avidity testing. Med. Princ. Pract. 23:29-33. http://dx.doi.org/10.1159/000354758.
19. Kanengisser-Pines B, Hazan Y, Pines G, Appelman Z. 2009. High cytomegalovirus IgG avidity is a reliable indicator of past infection in patients with positive IgM detected during the first trimester of pregnancy. J. Perinat. Med. 37:15-18. http://dx.doi.org/10.1515/JPM.2009.012.
20. Sonoyama A, Ebina Y, Morioko I, Tanimura K, Morizane M, Tairaku S, Minematsu T, Inoue N, Yamada H. 2012. Low IgG avidity and ultrasound fetal abnormality predict congenital cytomegalovirus infection. J. Med. Virol. 84:1928-1933. http://dx.doi.org/10.1002/jmv.23387.
21. Munro SC, Hall B, Whybin LR, Leader L, Robertson P, Maine GT, Rawlinson WD. 2005. Diagnosis of and screening for cytomegalovirus infection in pregnant women. J. Clin. Microbiol. 43:4713-4718. http://dx.doi.org/10.1128/JCM.43.9.4713-4718.2005.
22. Prince HE, Lapé-Nixon M, Novak-Weekley SM. 2014. Performance of a cytomegalovirus IgG enzyme immunoassay kit modified to measure avidity. Clin. Vaccine Immunol. 21:808-812. http://dx.doi.org/10.1128/CVI.00105-14.
23. Inouye S, Hasagawa A, Matsuno S, Katow S. 1984. Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed. J. Clin. Microbiol. 20:525-529.
24. Hedman K, Seppala I. 1988. Recent rubella virus infection indicated by a low avidity of specific IgG. J. Clin. Immunol. 8:214-221. http://dx.doi.org/10.1007/BF00917569.
25. Blackburn NK, Besselaar TG, Schoub BD, O'Connell KF. 1991. Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity. J. Med. Virol. 33:6-9. http://dx.doi.org/10.1002/jmv.1890330103.
26. Boppana SB, Britt WJ. 1995. Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection. J. Infect. Dis. 171:1115-1121. http://dx.doi.org/10.1093/infdis/171.5.1115.
27. Grangeot-Keros L, Mayaux MJ, Lebon P, Freymuth F, Eugene G, Stricker R, Dussaix E. 1997. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J. Infect. Dis. 175:944-996. http://dx.doi.org/10.1086/513996.
28. Bodeus M, Feyder S, Goubau P. 1998. Avidity of IgG antibodies distinguishes primary from non-primary cytomegalovirus infection in pregnant women. Clin. Diagn. Virol. 9:9-16. http://dx.doi.org/10.1016/S0928 -0197(97)10016-2.
29. Lazzarotto T, Spezzacatena P, Pradelli P, Abate DA, Varani S, Landini MP. 1997. Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects. Clin. Diagn. Lab. Immunol. 4:469-473.
30. Eggers M, Bader U, Enders G. 2000. Combination of microneutralization and avidity assays: improved diagnosis of recent primary human cytomegalovirus infection in single serum sample of second trimester pregnancy. J. Med. Virol. 60:324-330. http://dx.doi.org/10.1002/(SICI)1096 -9071(200003)60:3-324::AID-JMV11-3.0.CO;2-D.
31. Bodeus M, Van Ranst M, Bernard P, Hubinont C, Goubau P. 2002. Anticytomegalovirus IgG avidity in pregnancy: a 2-year prospective study. Fetal Diagn. Ther. 17:362-366. http://dx.doi.org/10.1159/000065386.
32. Lazzarotto T, Spezzacatena P, Varani S, Gabrielli L, Pradelli P, Guerra B, Landini MP. 1999. Anticytomegalovirus (anti-CMV) immunoglobulin G avidity in identification of pregnant women at risk of transmitting congenital CMV infection. Clin. Diagn. Lab. Immunol. 6:127-129.
33. Lazzarotto T, Varani S, Spezzacatena P, Gabrielli L, Pradelli P, Guerra B, Landini MP. 2000. Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus. Viral Immunol. 13:137-141. http://dx.doi.org/10.1089/vim.2000.13.137.
34. Bodeus M, Goubau P. 1999. Predictive value of maternal-IgG avidity for congenital human cytomegalovirus infection. J. Clin. Virol. 12:3-8.
35. Lazzarotto T, Varani S, Guerra B, Nicolosi A, Lanari M, Landini MP. 2000. Prenatal indicators of congenital cytomegalovirus infection. J. Pediatr. 137:90-95. http://dx.doi.org/10.1067/mpd.2000.107110.
36. Lazzarotto T, Varani S, Gabrielli L, Spezzacatena P, Landini MP. 1999. New advances in the diagnosis of congenital cytomegalovirus infection. Intervirology 42:390-397. http://dx.doi.org/10.1159/000053976.
37. Stagno S, Tinker MK, Elrod C, Fuccillo DA, Cloud G, O'Beirne AJ. 1985. Immunoglobulin M antibodies detected by enzyme-linked immunosorbent assay and radioimmunoassay in the diagnosis of cytomegalovirus infections in pregnant women and newborn infants. J. Clin. Microbiol. 21:930-935.
38. Grazia Revello M, Percivalle E, Zannino M, Rossi V, Gerna G. 1991. Development and evaluation of a capture ELISA for IgM antibody to the human cytomegalovirus major DNA binding proteins. J. Virol. Methods 35:315-329. http://dx.doi.org/10.1016/0166-0934(91)90073-9.
39. Daiminger A, Bader U, Eggers M, Lazzarotto T, Enders G. 1999. Evaluation of two novel enzyme immunoassays using recombinant antigens to detect cytomegalovirus-specific immunoglobulin M in sera from pregnant women. J. Clin. Virol. 13:161-171. http://dx.doi.org/10.1016/S1386-6532(99)00028-1.
40. Furione M, Rognoni V, Sarasini A, Zavattoni M, Lilleri D, Gerna G, Revello MG. 2013. Slow increase in IgG avidity correlates with prevention of human cytomegalovirus transmission to the fetus. J. Med. Virol. 85: 1960-1967. http://dx.doi.org/10.1002/jmv.23691.
41. de Souza S, Bonon SHA, Costa SCB, Rossi CL. 2003. Evaluation of an in-house specific immunoglobulin G (IgG) avidity ELISA for distinguishing recent primary from long-term human cytomegalovirus (HCMV) infection. Rev. Inst. Med. Trop. Sao Paulo 45:323-326. http://dx.doi.org/10.1590/S0036-46652003000600005.
42. Tagawa M, Minematsu T, Masuzaki H, Ishimaru T, Moriuchi H. 2010. Seroepidemiological survey of cytomegalovirus infection among pregnant women in Nagasaki, Japan. Pediatr. Intl. 52:459-462. http://dx.doi.org/10.1111/j.1442-200X.2009.03005.x.
43. Curdt I, Praast G, Sickinger E, Schultess J, Herold I, Braun HB, Bernhardt S, Maine GT, Smith DD, Hsu S, Christ HM, Pucci D, Hausmann M, Herzogenrath J. 2009. Development of fully automated determination of marker-specific immunoglobulin G (IgG) avidity based on the avidity competition assay format: application for Abbott Architect cytomegalovirus and toxo IgG avidity assays. J. Clin. Microbiol. 47:603-613. http://dx.doi.org/10.1128/JCM.01076-08.
44. Enders G, Daiminger A, Bader U, Exler S, Schimpf Y, Enders M. 2013. The value of CMV IgG avidity and immunoblot for timing the onset of primaryCMVinfection in pregnancy. J. Clin. Virol. 56:102-107. http://dx.doi.org/10.1016/j.jcv.2012.09.015.
45. Rajasekariah H, Scott G, Robertson PW, Rawlinson WD. 2013. Improving diagnosis of primary cytomegalovirus infection in pregnant women using immunoblot. J. Med. Virol. 85:315-319. http://dx.doi.org/10.1002/jmv.23471.
46. Bodeus M, Beulne D, Goubau P. 2001. Ability of three IgG-avidity assays to exclude recent cytomegalovirus infection. Eur. J. Clin. Microbiol. Infect. Dis. 20:248-252. http://dx.doi.org/10.1007/s100960100484.
47. Baccard-Longere M, Freymuth F, Cointe D, Seigneurin JM, Grangeot-Keros L. 2001. Multicenter evaluation of a rapid and convenient method for determination of cytomegalovirus immunoglobulin G avidity. Clin. Diagn. Lab. Immunol. 8:429-431. http://dx.doi.org/10.1128/CDLI.8.2.429-431.2001.
48. Dollard SC, Staras SAS, Amin MM, Schmid DS, Cannon MJ. 2011. National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity. Clin. Vaccine Immunol. 18:1895-1899. http://dx.doi.org/10.1128/CVI.05228-11.
49. Vauloup-Fellous C, Berth M, Heskia F, Dugua J-M, Grangeot-Keros L. 2013. Re-evaluation of the VIDAS® cytomegalovirus (CMV) IgG avidity assay: determination of new cut-off values based on the study of kinetics of CMV-IgG maturation. J. Clin. Virol. 56:118-123. http://dx.doi.org/10.1016/j.jcv.2012.10.017.
50. Revello MG, Gorini G, Gerna G. 2004. Clinical evaluation of a chemiluminescence immunoassay for determination of immunoglobulin G avidity to human cytomegalovirus. Clin. Diagn. Lab. Immunol. 11:801-805. http://dx.doi.org/10.1128/CDLI.11.4.801-805.2004.
51. Vauloup-Fellous C, Lazzarotto T, Revello MG, Grangeot-Keros L. 2 March 2014. Clinical evaluation of the Roche Elecsys® CMV IgG avidity assay. Eur. J. Clin. Microbiol. Infect. Dis. http://dx.doi.org/10.1007/s10096-014-2080-4.
52. Lagrou K, Bodeus M, Van Ranst M, Goubau P. 2009. Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays. J. Clin. Microbiol. 47:1695-1699. http://dx.doi.org/10.1128/JCM.02172-08.
53. Berth M, Grangeot-Keros L, Heskia F, Dugua J-M, Vauloup-Fellous C. 30 April 2014. Analytical issues possibly affecting the performance of commercial human cytomegalovirus IgG avidity assays. Eur. J. Clin. Microbiol. Infect. Dis. http://dx.doi.org/10.1007/s10096-014-2109-8.
54. Lumley S, Patel M, Griffiths PD. 2014. The combination of specific IgM antibodies and IgG antibodies of low avidity does not always indicate primary infection with cytomegalovirus. J. Med. Virol. 86:834-837. http://dx.doi.org/10.1002/jmv.23863.
55. Guisasola ME, Ramos B, Sanz JC, Garcia-Bermejo I, de Ory Manchon F. 2010. Comparison of IgG avidity assays in the confirmation of the diagnosis of cytomegalovirus primary infection. APMIS 118:991-993. http://dx.doi.org/10.1111/j.1600-0463.2010.02682.x.
56. Revello MG, Genini E, Gorini G, Klersy C, Piralla A, Gerna G. 2010. Comparative evaluation of eight commercial human cytomegalovirus IgG avidity assays. J. Clin. Virol. 48:255-259. http://dx.doi.org/10.1016/j.jcv.2010.05.004.
57. Prince HE, Lapé-Nixon M, Brenner A, Pitstick N, Couturier MR. 2014. Potential impact of different cytomegalovirus (CMV) IgM assays on an algorithm requiring IgM reactivity as a criterion for measuring CMV IgG avidity. Clin. Vaccine Immunol. 21:813-816. http://dx.doi.org/10.1128/CVI.00106-14.
58. Lazzarotto T, Gabrielli L, Lanari M, Guerra B, Bellucci T, Sassi M, Landini MP. 2004. Congenital cytomegalovirus infection: recent advances in the diagnosis of maternal infection. Hum. Immunol. 65:410-415. http://dx.doi.org/10.1016/j.humimm.2004.02.006.
59. Prince HE, Leber AL. 2002. Validation of an in-house assay for cytomegalovirus immunoglobulin G (CMV IgG) avidity and relationship of avidity to CMV IgM levels. Clin. Diagn. Lab. Immunol. 9:824-827. http://dx.doi.org/10.1128/CDLI.9.4.824-827.2002.
60. Lazzarotto T, Guerra B, Gabrielli L, Lanari M, Landini MP. 2011. Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy. Clin. Microbiol. Infect. 17:1285-1293. http://dx.doi.org/10.1111/j.1469-0691.2011.03564.x.
61. Lazzarotto T, Galli C, Pulvirenti R, Rescaldani R, Vezzo R, La Gioia A, Martinelli C, La Rocca S, Agresti G, Grillner L, Nordin M, Van Ranst M, Combs B, Maine GT, Landini MP. 2001. Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulinM(IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay. Clin. Diagn. Lab. Immunol. 8:196-198. http://dx.doi.org/10.1128/CDLI.8.1.196-198.2001.
62. Maine GT, Stricker R, Stricker R. 2012. Kinetics of CMV seroconversion in a Swiss pregnant women population. Diagn. Microbiol. Infect. Dis. 73:275-277. http://dx.doi.org/10.1016/j.diagmicrobio.2012.03.016.
63. Gentile M, Galli C, Pagnotti P, Di Marco P, Tzantzoglou S, Bellomi F, Ferreri ML, Selvaggi C, Antonelli G. 2009. Measurement of the sensitivity of different commercial assays in the diagnosis of CMV infection in pregnancy. Eur. J. Clin. Microbiol. Infect. Dis. 28:977-981. http://dx.doi.org/10.1007/s10096-009-0738-0.
64. Macé M, Sisoeff L, Rudent A, Grangeot-Keros L. 2004. A serological testing algorithm for the diagnosis of primary CMV infection in pregnant women. Prenat. Diagn. 24:861-863. http://dx.doi.org/10.1002/pd.1001.
65. Johnson JM, Anderson BL. 2013. Cytomegalovirus: should we screen pregnant women for primary infection? Am. J. Perinatol. 3:121-124. http://dx.doi.org/10.1055/s-0032-1333133.
66. Adler SP, Finney JW, Manganello AM, Best AM. 2004. Prevention of child-to-mother transmission of cytomegalovirus among pregnant women. J. Pediatr. 145:485-491. http://dx.doi.org/10.1016/j.jpeds.2004.05.041.
67. Baquero-Artigao F, Grupo de Trabajo de Tuberculosis de la Sociedad Española de Infectolog ía Pediátrica. 2009. Consensus document from the Spanish Society of Paediatric Infectious Diseases (SEIP) on the diagnosis and treatment of congenital cytomegalovirus infection. An. Pediatr. (Barc.) 71:535-547. (In Spanish.) http://dx.doi.org/10.1016/j.anpedi.2009.07.029.
68. Yinon Y, Farine D, Yudin MH, Gagnon R, Hudon L, Basso M, Bos H, Delisle MF, Menticoglou S, Mundle W, Ouellet A, Pressey T, Roggensack A, Boucher M, Castillo E, Gruslin A, Money DM, Murphy K, Ogilvie G, Paquet C, Van Eyk N, van Schalkwyk J, Fetal Medicine Committee Society of Obstetricians and Gynaecologists of Canada. 2010. Cytomegalovirus infection in pregnancy. J. Obstet. Gynaecol. Can. 32:348-354.